ABSTRACT Regulatory RNA binding proteins allow for specific control of gene expression in a very dynamic manner. In mammals ZFP36, formerly known as Tristetraprolin, controls the inflammatory response by binding to an AU-rich element located in the 3' untranslated region of its target mRNAs. The developping embryo relies on a population of primitive macrophages to ensure proper immunity. Although the role of zfp36 in adult immunity has been extensively studied, its expression in the developing immune system has been poorly documented. Here, we have used whole mount in situ hybridization with a 3' UTR specific probe to address the expression of zfp36 in developing Xenopus tropicalis embryos. We have shown that zfp36 is expressed in two distinct cellular populations. First, it is a new marker of primititive myeloid cells, being coexpressed with the myeloid marker mpo. Therefore this early expression may suggest a role for zfp36 in macrophage differentiation and activation. In addition, a second cell population was found to transiently express zfp36, but not mpo, along the fusing neural folds and may correspond to cells undergoing autophagy during neural tube closure.
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ZFP36 formerly known as Tristetraprolin (TTP) (Lai et al., 2014) belongs to a family of RNA binding Zinc Fingers containing proteins which is composed of 3 members in humans, ZFP36, ZFP36L1 and ZFP36L2. In Xenopus laevis, a fourth member previously called C3H4 and named Zfp36L4 has been identified (Belloc and Méndez, 2008; De et al., 1999; Tréguer et al., 2013) .
Functionally, ZFP36 has been shown to regulate post-transcriptionnally the inflammatory response by controling the expression level of inflammatory factors such as TNF-alpha (Carballo et al., 1998) or GM-CSF . Mice constitutively deficient for ZFP36, albeit apparently normal at birth develop a debilitating inflammatory response (Taylor et al., 1996) . ZFP36 acts through the specific binding to AU-rich element present in the 3'UTR of the targeted mRNAs and triggers their destabilization .
Extensive work has been conducted to address the function of ZFP36 in the regulation of inflammatory processes while its expression in the developing immune system has been loosely documented. Xenopus is a useful model system to study the multiple steps of early immune system development (Ciau-Uitz et al., 2010) . In Xenopus embryos, primitive hematopoiesis is initiated in a ventral region termed the ventral blood island (VBI) that is the equivalent of the mammalian extraembryonic yolk sac. The VBI is composed of two areas, the anterior VBI (aVBI) and the posterior VBI (pVBI) that give rises to different cell populations. The aVBI originates from blastomeres C1D1 and comprises an hemangioblast-like population of cells expressing both blood and endothelial cell markers at stage 14. Yet, it has recently been shown that in normal situation the aVBI will only produce blood cells (Myers and Krieg, 2013) , the myeloid lineage being highly represented among those. These myeloid cells can be clearly distinguished by following the expression of a peroxidase family member, the myeloperoxidase (mpo also know as xpox2, (Smith et al., 2002) ). mpo expression is first detected in the aVBI of early neurula at stage 13 (Tashiro et al., 2006) . mpo-positive cells undergo proliferation before differentiating and migrating throughout the embryos from stage 19-20. The migrating cells navigate in between the ectodermal and mesodermal layer and in between the mesodermal and endodermal layer. The mpo-positives cells are functional myeloid cells that are recruited upon wound healing in Xenopus tadpoles (Costa et al., 2008) .
In Xenopus as in human the embryonic macrophages are central for the innate immunity of the developing embryos until the adaptative immune system develop later on. They play multiple functions by providing an innate immune function, participating in wound healing (Costa et al., 2008) , promoting heart formation (Smith and Mohun, 2011) and in clearing the embryo of apoptotic cells (Hopkinson-Woolley et al., 1994) . This last function is particularly important during development since apoptosis is fundamental to many developmental processes (Fuchs and Steller, 2011) . In particular, apoptosis is observed during neural tube closure in mice where it is required for proper zipping of the neural ridge (Yamaguchi et al., 2011) .
Expression of zfp36 can be induced rapidly through various stimulation with cytokines, insulin or growth factors (Sanduja et al., 2012) . It is also rapidly induced in macrophages following their activation by bacterial pathogens (Nau et al., 2002) . A recent study on the ZFP36 family of RNA binding protein in Xenopus laevis presented the expression pattern for the 4 members of this family (Tréguer et al., 2013) . Particularly, the expression pattern of zfp36 was presented from stage 24 to stage 34. The authors showed that zfp36 was detected in somites, cement gland and presented a punctate staining in the lateral mesoderm of the embryos by stages 24, staining that disappeared in later stages embryos. The ontological origine of this staining was not assessed. This prompted us to precise the early zfp36 expression using the diploid Xenopus tropicalis.
Results
Considering that ZFP36 is a protein with a prevalent role in the control of inflammatory process, we hypothesized that the punctate staining observed by Treguer and colleagues (Tréguer et al., 2013) could be originating from the population of migratory macrophages. To address this hypothesis we first tested wether the published staining pattern was reproducible in X. tropicalis.
To avoid potential cross-hybridization with the three paralogs, an antisense probe encompassing sequences corresponding to the 3' UTR was used to perform whole mount in situ hybridization (ISH) of late neurulae (stage 20) and tailbud embryos (stage 26) (Fig.  1) . Consistent with the study of Tréguer and colleagues (Tréguer et al., 2013) a punctate staining was present at both stages. In late neurula (st. 20), this labelling was centered on the ventral region that corresponds likely to the aVBI while at stage 26 the labelled cells extended all over the surface of the embryo. At the tailbud stage a denser area of punctate staining was detected just above the cement gland but this structure itself was not stained. Finally in contrast to the published data no labelling was detected in the somites either at the neurula or tailbud stages ( Fig. 1 lateral view) .
To determine whether zfp36 is expressed in cells of the myeloid lineage we conducted sequential double in situ hybridization with zfp36 and mpo a specific myeloid marker. zfp36 and mpo specific probes were labeled respectively with digoxygenin and fluores- cein. Probes were revealed sequentially with anti-DIG/alkaline phosphatase and anti-fluorescein/alkaline phosphatase antibodies using NBT-BCIP as substrate. Phosphatase activity was killed by dehydration in methanol inbetween immunodetection of each label. As described above, revelation of zfp36 expression showed that ventrally zfp36-positive cells are localized in the anterior part of the embryo in an area compatible with the aVBI. The subsequent detection of mpo showed an increase in NBT/BCIP signal in this region of the embryos in the same cells showing that at stage 18 the ventrally zfp36-positive cells express mpo ( Fig. 2A) . At stage 26 when the zfp36-positive cells have migrated and colonized the whole embryo the coexpression with mpo was more clearly observed, each zfp36-positive cell being also mpo-positive ( Figure  2A right panel) . To refine the location of mpo or zfp36 expressing cells transversal section of stage 20 embryos stained for mpo or zfp36 were also realized. (Fig. 2B right panel) . Both mpo and zfp36 expressing cells were located under the ectoderm in a location where the migration of myeloid cells take place (Fig. 2B) . We therefore concluded that zfp36 is expressed in the primitive myeloid cells that originate from the aVBI and differentiate further into migratory embryonic macrophages.
Interestingly at stage 18 a second cell population expressing zfp36 was also observed close to the tips of the fusing neural folds with a stronger signal at the anterior and posterior ends (neuropores) (Fig. 2A) . These dorsal zfp36-positive cells do not present any obvious increase in signal in the sequential double in situ hybridization when revealed for mpo. In addition, while in transverse sections a few number of zfp36-positive cells specifically located along the neural fold could be observed (Fig. 2B middle panel, arrowhead) the mpo staining was only detected ventrally ( Fig. 2B left panel) suggesting these cells do not correspond to migratory macrophages.
To determine if mpo staining could be observed dorsally along the neural fold we conducted single in situ hybridization for mpo on embryos at stages 19-21. We could never detect any labelling along the neural folds (Fig. 2C, left panel) while mpo-positive cells were distinctly detected ventrally. On the contrary, a few zfp36-positive cells were clearly detected along the neural folds. Importantly, their number and localization varied from one embryo to the other suggesting they participate in a very dynamic process. This further confirm that zfp36 labeled at least two different cell populations, a ventral population characterized both by mpo and zfp36 expression and a population of cells expressing only zfp36 and localized along the fusing neural folds.
To address more precisely the temporal expression pattern of zfp36 in early embryos we conducted both qRT-PCR and ISH for zfp36 mRNA during development (Fig. 3) . When analyzed by RT-QPCR (Fig. 3A) , zfp36 mRNA was undetected in unfertilized eggs and first detected in stage 10 embryos, accumulating during the neurulation to reach a plateau by stage 23. zfp36 expression was increased by about 3 fold between stage 12 and stage 23 while mpo mRNA levels increased at least 10 fold between stage 16, when it was first detected, and stage 26. The earliest zfp36 expression we could detect by in situ hybridization was at stage 14 in the most anterior part of the ventral mesoderm (Fig. 3B) . zfp36 expression could then be detected ventrally as a spotted pattern in stage 16 embryos. At this stage, no dorsal zfp36 labeling was present along the neural folds, the blue background being a non-specific staining. The ventral localisation of zfp36 was further confirmed in later stages 19 and 21 embryos when zfp36-positive cells become more individualized and migrate away from the ventral midline. At stage 24 a distinct salt and pepper pattern covered loosely the whole embryos. At stages 19 and 21, zfp36-positive cells were detected along the neural fold where the neural tube closes. Frontal view of stages 19 and 21 embryos allowed the visualization of both ventral and dorsal staining. By stage 24 no zfp36-positive cells could be detected dorsally along the neural tube. By stage 32 (Fig. 3C ) the punctate staining as vanished but a dense zfp36 specific staining was observed ventrally close to the heart field. This staining is highly similar to the reported expression of mpo at this stage (Smith et al., 2002) . 
Discussion
Our data showed that zfp36 is first expressed around stage 14 in the antero-ventral part of the embryo in an area corresponding to the aVBI. Lately, the expression spread to cover the whole embryo in a spotted pattern by the late tailbud stage. Double in situ hybridizations with mpo, a marker of the myeloid cell lineage has revealed that these cells correspond to population of migratory macrophages that move under the ectoderm and define therefore zfp36 as a new marker of the embryonic myeloid lineage. Such an expression of zfp36 in primitive myeloid cells originating from the aVBI in Xenopus is in agreement with its expression in the adult myeloid lineage in mammals. In adult macrophages ZFP36 destabilizes pro-inflammatory transcripts among which TNF-alpha by binding to the AU-rich element of its 3' untranslated region (Rewieved in (Sanduja et al., 2012) ). This inactivation by ZFP36 is central in an autoregulatory feedback loop that limits the inflammatory response. The X. tropicalis TNF 3'UTR being also highly rich in AU-rich element suggests a conservation of the process at play. Yet nothing is known on the role of Zfp36 in the establishment of the primitive myeloid lineage.
We could not detect any expression in the dorsal lateral plate at any stages of development ruling out an early expression of zfp36 in a domain that will give rise to adult blood cells.
In contradiction to what has been previously reported in X. laevis, no expression of zfp36 in the somites and the cement gland was observed in X. tropicalis. These differences may originate from cross-hybridization of the full length probe used in the former study with the other paralogs. Alternatively in X. laevis the duplicated zfp36 genes may display different expression patterns. Interestingly, comparative transcriptomic analysis of X. laevis and X. tropicalis gene expression highlighted divergence in the temporal expression of genes involved in innate immunity (Yanai et al., 2011) . These temporal divergence could be accompanied by divergence in the spatial expression as we observe here for zfp36.
Importantly, between stage 19 and stage 22, zfp36 is also expressed in a few number of cells specifically located at the extremity of the fusing neural folds. Their number and localization vary from one embryo to the other and they do not express mpo. This therefore raises two important questions:
Origin of zfp36-positive cells and function in the fusing neural fold
Data from the litterature do not show any specific expression of hematopoietic genes along the neural folds in stages when zfp36 is expressed (Chen et al., 2009 ). In addition, it is unlikely that these zfp36-positive cells migrate from the aVBI as the migration of the myeloid cells has just started when zfp36 neuropore staining is first observed, indicating they are not migratory macrophages. This suggests that zfp36-positive mpo-negative cells located along the neural fold are not originating from the aVBI and define therefore a distinct subpopulation of specialized cells. Furthermore the expression of zfp36 in these cells is very transitory as later stage embryos do not present zfp36 staining along the neural tube suggesting they participate in a very dynamic process. In Xenopus, the expression pattern of beclin1, at stage 19 is partially similar to the expression of zfp36 with a distinctive speckled pattern along the neural fold (Bowes et al., 2010) . Beclin-1 is involved in the activation of the autophagy pathway a process which is accompanied by an increase in ERK signaling (Florkowska et al., 2012; Martinez-Lopez et al., 2013) . Because neural tube closure appears as being critically controlled by autophagy and apoptosis (Cecconi et al., 2008) it is therefore possible that zfp36 labelling along the neural folds represent a transient activation of zfp36 expression in cells undergoing apoptosis or autophagy.
In conclusion, we have shown that zfp36 is a new marker of primititive myeloid cells whose early expression is compatible with a role in macrophage differentiation and activation. In addition, a second cell population express transiently zfp36 along the fusing neural folds and may correspond to cells undergoing autophagy during the neural tube closure. To study further the functions of ZFP36 in both cell lineages it will be of interest to use functionnal approaches including loss of function experiments.
Material and Methods

Xenopus tropicalis in vitro fertilization
X. tropicalis female were primed with 15U hCG (Organon) the day before fertilization experiment. Fourteen hours later female were induced to lay eggs by injection of 100U hCG. Testis were dissected from a X. tropicalis male and dilascerated in 300 ml of L15 medium complemented with 10% FBS. Eggs freshly collected from the females were covered with the testis suspension for 3 min and overlaid with water from the aquarium. After 20 min, eggs were dejellied in 2 % cysteine in 1X F1 (Hepes 10 mM,NaHCO 3 2 mM, CaCl 2 0,25 mM, MgCl 2 0.6 mM, NaCl 31 mM, KCl 1.75 mM) at pH 7.9, rinsed in 1X F1. Dejellied embryos were allowed to develop at 22°C on plastic petri dishes covered with 1% agar in water. Embryos were transfered to 0.1X F1 five hours after fertilization. At the chosen time of development, embryos were fixed for 2 hours in freshly prepared MEMFA (0.1 M MOPS pH 7.4, 2 mM EGTA,1 mM MgSO 4 , 3.7% formaldehyde) rinsed in PBS and stored in MeOH at -20°C.
Clones, templates and probe preparation
Plasmids containing the full length cDNA for mpo (BQ522393, IMAGEID 5336501) and zfp36 (BC154918, IMAGEID 8911341) were obtained from Source BioScience. Templates for in vitro transcription were as follow: zfp36, 3' UTR, antisense probe, NheI, T7; zfp36, 3' UTR, antisense probe, NheI, SP6. mpo, full length, sense probe, XbaI,SP6; mpo, full length, antisense probe, EcoRI, T7.
Full length or 3' UTR digoxygenin (Roche) or fluorescein (PerkinElmer) labeled antisense and sense probe were generated by in vitro transcription using either T7 or SP6 RNA polymerase (Promega) as indicated above.
In situ hybridization, vibratome sectioning
Whole mount in situ hybridization were realized essentially as described in (Harland, 1991) . Detection was carried out using anti-DIG or anti-fluorescein Alkaline Phosphatase conjugated antibodies (Roche) and stained with NBT/BCIP (Promega) as substrate. Embryos were bleached in 1.2 % hydrogen peroxide in SSC. For detailed analysis embryos treated for whole mount in situ hybridization and stored in PBST were embedded in 5 % agar and sectioned on a LEICA VT 1200S vibratome at 50 mm thickness as described in (Noiret et al., 2012) . Pictures were taken on a Leica Z16 APO macroscope.
RNA extraction and RT-QPCR
Total RNA was extracted from pool of 10 Xenopus tropicalis embryos at the indicated stages (Nieuwkoop and Faber, 1994) using Tri-reagent following manufacturer recommendations(Molecular Research center). Genomic contamination was eliminated by treatment with TurboTM Dnase (Ambion) Total RNA was reverse transcribed using random primers and Superscript II reverse transcriptase (Invitrogen). QPCR was performed on a qPCR7900 HT (Applied Biosystems) using the Sybr Green Master mix (Life Technologies) with the following oligonucleotides pairs: odc (Noiret et al., zfp36 expression in Xenopus tropicalis 755 2012), mpo (Costa et al., 2008) , zfp36_forward caaaccgtcacccaaagtataa, zfp36_reverse tgcttggcacaccagaatag. QPCR results were normalized to odc levels.
